Lymphoma Research Foundation hosts annual gala in NYC

On October 5, 2011 New York City's Chelsea Piers will play host to the largest non-profit in the country that is fully devoted to funding lymphoma research and to helping those with the disease and their loved ones, the Lymphoma Research Foundation (LRF), as it throws its annual gala recognizing the contributions of a select group of honorees.

Hosted by broadcast journalist Harry Smith, events include a silent auction as well as a live auction, with proceeds going towards the Foundation.

Philanthropic and corporate leadership awards will be presented to selected individuals and companies that have had a meaningful impact on helping the Foundation advance its mission.

The Freundlich Award honoree:
The Werner Family.

Corporate Leadership Award honorees:
Celgene Corporation
Genentech BioOncology

Said Diane Blum, the Foundation's CEO, "The Lymphoma Research Foundation is committed to eradicating lymphoma and serving those touched by this disease. The dedication of the Foundation's supporters, especially of those whom we are honoring at this year's gala, is instrumental to LRF's progress. LRF extends our sincerest gratitude to all of our supporters for their ongoing support of our vital mission."

2011 Co-Chairs:
Miriam & David Phalen
Sheri & Jimmy Rosenfeld

For more information about the Lymphoma Research Foundation's annual gala or to purchase tickets to the event, contact Taylor Zitay at (646) 465-9103.

For additional information about lymphoma check out the LRF's website at lymphoma.org

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap